Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Hans-peter Gerber

Chief Scientific Officer at Sutro Biopharma, Inc. (STRO)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+43.9%
vs. S&P 500+39.1%
Beat the market100%
Paper profit on buys+$229K
Total bought / sold$14K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Oct 16SEC STROSutro Biopharma, Inc. Buy 17,00071,832 held (+31%) $0.80 $14K +1683.7%
  • Buy

    Chief Scientific Officer Hans-peter Gerber bought $14K of STRO at $0.80 — first open-market purchase in our records; raises the stake by 31%.